Early Pharmacotherapy Aimed at Neuroplasticity in Autism : Safety and Efficacy
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy, safety, and population
pharmacokinetics and determinants of drug responses to buspirone in children with autism
using a randomized, double blind, cross over study in children ages 2 to 6 years.